NASDAQ · Healthcare · Biotechnology
Summit Therapeutics Inc.
SMMT
Summit Therapeutics Inc. CEO Robert W. Duggan · Market cap $10.5B.
$13.16
+0.73 · +5.87%
52w hi $30.0552w lo $12.07
Off 52w high 54.8%
80
STRONG
Current InsiderScore
Corp · 90d
5
5 buys · 0 sales
Cong · 90d
0
0 buys · 0 sales
Signals ≥ 60 · 12mo
12
8 strong · 4 notable
Analyst consensus
Strong Buy
Avg PT $19.00
Section 01
Recent Form 4 filings
12 filings on file
| Date | Insider | Role | Action | Shares | Price | Value | Score |
|---|---|---|---|---|---|---|---|
| Jun 12 | Robert W Duggan | Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | +$49.99M | 78 |
| Jun 12 | Mahkam Zanganeh | Co-Chief Executive Officer | Buy | 3,810,000 | $13.12 | +$49.99M | 78 |
| Jun 04 | Robert W Duggan | Co-Chief Executive Officer | Buy | 100,000 | $14.60 | +$1.46M | 80 |
| Jun 04 | Mahkam Zanganeh | Co-Chief Executive Officer | Buy | 100,000 | $14.60 | +$1.46M | 80 |
| Jun 04 | Manmeet Singh Soni | COO and CFO | Buy | 25,000 | $14.46 | +$362K | 71 |
| Oct 21 | Robert W Duggan | Co-Chief Executive Officer | Buy | 26,680 | $18.74 | +$500K | 87 |
| Oct 21 | Mahkam Zanganeh | Co-Chief Executive Officer | Buy | 26,680 | $18.74 | +$500K | 87 |
| Oct 21 | Yu Xia | Buy | 533,617 | $18.74 | +$10.00M | 74 | |
| Sep 11 | Robert W Duggan | Co-Chief Executive Officer | Buy | 5,000 | $18.07 | +$90K | 66 |
| Sep 11 | Mahkam Zanganeh | Co-Chief Executive Officer | Buy | 5,000 | $18.07 | +$90K | 66 |
| Sep 10 | Robert W Duggan | Co-Chief Executive Officer | Buy | 333,394 | $17.68 | +$5.89M | 78 |
| Sep 10 | Mahkam Zanganeh | Co-Chief Executive Officer | Buy | 333,394 | $17.68 | +$5.89M | 78 |
Section 02
Recent STOCK Act disclosures
No disclosures yet
No STOCK Act disclosures on record for this ticker.
Section 03
InsiderScore history
Rolling 12 months · peak score per month
SepOctNovDecJanFebMarAprMayJunJulAug